Disitamab Vedotin (RC48-ADC) in Patients With Breast Cancer: a Real-world Study
Disitamab Vedotin (RC48-ADC) in Patients With Breast Cancer: a Real-world Study
To evaluate the efficacy and safety of Disitamab vedotin (RC48-ADC) in patients with breast cancer.
Inclusion Criteria:
Exclusion Criteria:
yinwenjin@renji.com86(21)68385569